Cargando…
Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240461/ https://www.ncbi.nlm.nih.gov/pubmed/34214517 http://dx.doi.org/10.1016/j.jinf.2021.06.023 |
_version_ | 1783715222192652288 |
---|---|
author | Hsu, Lea Wisplinghoff, Hilmar Kossow, Annelene Hurraß, Julia Wiesmüller, Gerhard A. Grüne, Barbara Hoffmann, Dennis Lüsebrink, Jessica Demuth, Sabrina Schildgen, Oliver Schildgen, Verena |
author_facet | Hsu, Lea Wisplinghoff, Hilmar Kossow, Annelene Hurraß, Julia Wiesmüller, Gerhard A. Grüne, Barbara Hoffmann, Dennis Lüsebrink, Jessica Demuth, Sabrina Schildgen, Oliver Schildgen, Verena |
author_sort | Hsu, Lea |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8240461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82404612021-06-29 Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination Hsu, Lea Wisplinghoff, Hilmar Kossow, Annelene Hurraß, Julia Wiesmüller, Gerhard A. Grüne, Barbara Hoffmann, Dennis Lüsebrink, Jessica Demuth, Sabrina Schildgen, Oliver Schildgen, Verena J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-06-29 /pmc/articles/PMC8240461/ /pubmed/34214517 http://dx.doi.org/10.1016/j.jinf.2021.06.023 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Hsu, Lea Wisplinghoff, Hilmar Kossow, Annelene Hurraß, Julia Wiesmüller, Gerhard A. Grüne, Barbara Hoffmann, Dennis Lüsebrink, Jessica Demuth, Sabrina Schildgen, Oliver Schildgen, Verena Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title | Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title_full | Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title_fullStr | Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title_full_unstemmed | Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title_short | Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination |
title_sort | limited protection against sars-cov-2 infection and virus transmission after mrna vaccination |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240461/ https://www.ncbi.nlm.nih.gov/pubmed/34214517 http://dx.doi.org/10.1016/j.jinf.2021.06.023 |
work_keys_str_mv | AT hsulea limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT wisplinghoffhilmar limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT kossowannelene limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT hurraßjulia limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT wiesmullergerharda limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT grunebarbara limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT hoffmanndennis limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT lusebrinkjessica limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT demuthsabrina limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT schildgenoliver limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination AT schildgenverena limitedprotectionagainstsarscov2infectionandvirustransmissionaftermrnavaccination |